Acadia Healthcare (NASDAQ:ACHC) Updates FY 2025 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 2.500-2.800 for the period, compared to the consensus estimate of 3.360. The company issued revenue guidance of $3.3 billion-$3.4 billion, compared to the consensus revenue estimate of $3.4 billion. Acadia Healthcare also updated its Q1 2025 guidance to EPS.

Acadia Healthcare Trading Down 1.8 %

Shares of NASDAQ ACHC opened at $40.26 on Friday. The company has a market cap of $3.74 billion, a PE ratio of 13.20, a P/E/G ratio of 1.46 and a beta of 1.30. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $86.67. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm’s 50 day moving average price is $42.26 and its 200-day moving average price is $52.22.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on ACHC shares. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Barclays decreased their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. KeyCorp upgraded Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a report on Tuesday, January 7th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $64.00 price objective on shares of Acadia Healthcare in a report on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $70.22.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.